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Background: During the first trimester of pregnancy, a series of tightly regulated interactions govern the formation
of a highly invasive population of fetal-derived extravillous cytotrophoblasts (EVT). Successful pregnancy is
dependent on efficient invasion of the uterine wall and maternal spiral arteries by EVT. Dysregulated trophoblast
invasion is associated with intrauterine growth restriction, birth defects, spontaneous abortion and preeclampsia. A
number of soluble growth factors, cytokines, and chemokines modulate this process, fine-tuning the temporal and
spatial aspects of cytotrophoblast invasion. In particular, the CXCL12/CXCR4 axis has been shown to specifically
modulate cytotrophoblast differentiation, invasion, and survival throughout early pregnancy. Infection with human
cytomegalovirus (HCMV) has been associated with impaired differentiation of cytotrophoblasts down the invasive
pathway, specifically dysregulating the response to mitogens including epidermal growth factor (EGF) and
hepatocyte growth factor (HGF). In this study, the effect of HCMV infection on the CXCL12-mediated migration and
invasion of the EVT cell line SGHPL-4 was investigated.
Results: Infection with HCMV significantly decreased secretion of CXCL12 by SGHPL-4 cells, and induced a striking
perinuclear accumulation of the chemokine. HCMV infection significantly increased mRNA and total cell surface
expression of the two known receptors for CXCL12: CXCR4 and CXCR7. Functionally, HCMV-infected SGHPL-4 cells
were unable to migrate or invade in response to a gradient of soluble CXCL12 in transwell assays.
Conclusions: Collectively, these studies demonstrate that HCMV impairs EVT migration and invasion induced by
CXCL12. As HCMV has the ability to inhibit EVT migration and invasion through dysregulation of other relevant
signaling pathways, it is likely that the virus affects multiple signaling pathways to impair placentation and
contribute to some of the placental defects seen in HCMV-positive pregnancies.
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Primary infection with human cytomegalovirus (HCMV)
during the first trimester of pregnancy is associated with
poor pregnancy outcomes, including intrauterine growth
restriction (IUGR), birth defects, preeclampsia, and spon-
taneous abortion [1-3]. Specifically, HCMV has been shown
to productively infect placental cytotrophoblasts. These* Correspondence: cmorris2@tulane.edu
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reproduction in any medium, provided the orcells undergo differentiation through a series of tightly
regulated processes involving soluble growth factors, hor-
mones and chemokines during the first trimester, resulting
in an invasive subpopulation of cells termed extravillous
cytotrophoblasts (EVT). EVT invade the uterine wall and
remodel the spiral arteries within the endometrium and
myometrium, producing a hybrid fetal-maternal vasculature
necessary for the maintenance of pregnancy [4-7]. Inad-
equate trophoblast invasion impairs blood, oxygen and nu-
trient flow to the developing fetus, and can lead to shallow
placentation and poor pregnancy outcomes for both
mother and fetus [8-10]. Productive HCMV infection of
cytotrophoblasts induces downregulation of cell surfaceLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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rin, as well as the non-classical MHC molecule HLA-G,
which may alter the immune response to infected cells
[11,12]. Additionally, HCMV infection inhibits prolifera-
tion, matrix metalloproteinase (MMP) production, and
invasion of extracellular matrix by the human first
trimester-derived EVT cell line SGHPL-4, indicating that
the virus blocks differentiation down an invasive pathway
in EVT [13]. The molecular mechanism(s) by which
HCMV inhibits EVT migration and invasion is not known.
The chemokine CXCL12, through interaction with the
CXCR4 receptor, modulates differentiation and migra-
tion of a number of cell types, such as those in the cen-
tral nervous system and in solid organ neoplasms
including kidney, breast and ovarian cancers [14-19].
This chemokine also plays an integral role in EVT differ-
entiation and invasion during early stages of placenta-
tion. CXCL12 induces proliferation and invasion in both
cytotrophoblast cell lines and primary placental tissues
[20-22]. Via interaction with CXCR4, CXCL12 mediates
cytotrophoblast proliferation, MMP production, and in-
vasion through basement membranes via activation of
the mitogen-activated protein kinase (MAPK) pathway
[20,21,23]. Recently, CXCL12 has been shown to bind
to and activate a second receptor, CXCR7. Although
G-protein coupled receptor activity has not been
demonstrated for CXCR7, it appears to modulate the
cellular response to CXCL12 via heterodimerization with
CXCR4 as well as via induction of ligand sequestration
during migration [24-28]. CXCR7, like CXCR4, is
expressed in placental tissue; however, a specific role for
this receptor in trophoblast function and placental de-
velopment has not yet been defined [29,30]. Recent stud-
ies suggest that during the first trimester of pregnancy,
cytotrophoblast-derived CXCL12 regulates the extent of
EVT invasion by inducing expression of CD82 by decid-
ual stromal cells, thereby preventing excessive invasion
of the placenta into the uterine wall [31].
The aim of this study was to determine the effect of
HCMV infection on cellular distribution and expression
of CXCL12 and its receptors, CXCR4 and CXCR7, and
on EVT migration and invasion in response to CXCL12.
Results
HCMV infection induces sequestration of endogenous
CXCL12 in the extravillous cytotrophoblast cell line,
SGHPL-4
Immunofluorescence staining was performed to com-
pare the cellular distribution of CXCL12 in mock- versus
HCMV-infected cells. Serum-starved SGHPL-4 cells
were either mock-infected or infected with HCMV iso-
lated laboratory strains Towne (high passage) or Toledo
(low passage), and the clinical strain TRpM1a, for 24
hours, at which point they were fixed and stained forCXCL12. As shown in Figure 1, infection with all three
viral strains induced a stark alteration in the distribution
of CXCL12. Mock-infected cells (Figure 1A) displayed
diffuse staining for CXCL12. In contrast, in HCMV-
infected cells (Figure 1B-D), CXCL12 was tightly clus-
tered in a perinuclear staining pattern.
To assess whether viral gene expression is required for
sequestration of CXCL12, SGHPL-4 cells were also
infected with UV-inactivated Towne-GFP for 24 hours,
at which point they were fixed and stained as above. No
GFP expression was seen in cells infected with UV-
inactivated HCMV, demonstrating a lack of viral gene
expression (data not shown). UV-inactivated HCMV did
not induce the perinuclear sequestration of CXCL12
(Figure 1E) seen after infection with wild-type virus.
Staining with isotype-matched secondary antibodies
alone served as a negative control (Figure 1F). These
data indicate that expression of viral genes, rather than
the activity of pre-packaged virion-associated proteins, is
required for the altered distribution pattern of CXCL12
seen post-infection.
Secretion of CXCL12 is decreased in HCMV-infected EVT
To assess cellular secretion of CXCL12 following HCMV
infection, cell culture supernatants were analyzed by
ELISA (Figure 2A). Baseline secretion of CXCL12 in
mock-infected cells increased between 24 and 72 hours
in culture, at which point it declined. HCMV infection
significantly decreased the concentration of CXCL12 in
the supernatants at 24, 48, 72, and 96 hours post-
infection (p<0.05).
Expression of CXCL12 at the mRNA level is unchanged by
HCMV infection
Serum-starved SGHPL-4 cells were infected with HCMV
or UV-inactivated virus and RNA lysates were harvested
at 2, 8, 24, or 48 hours post-infection with HCMV.
Quantitative real-time PCR was performed using specific
primers to CXCL12 (Table 1). All threshold values were
normalized to the 36B4 ribosomal housekeeping gene.
Infection with HCMV did not significantly alter mRNA
expression of CXCL12 at any timepoint analyzed
(Figure 2B). UV-inactivated HCMV also did not affect
mRNA expression of CXCL12 (data not shown).
HCMV infection alters expression of CXCR4 and CXCR7 at
the cell surface
Given perinuclear sequestration and decreased secretion
of CXCL12 following HCMV infection of SGHPL-4
cells, the abundance and distribution of the CXCL12
receptors, CXCR4 and CXCR7, were also analyzed. Sur-
face expression of CXCR4 and CXCR7 was assessed by
flow cytometry. Mock-infected or HCMV-infected
SGHPL-4 cells were harvested and surface-stained for
Figure 1 SGHPL-4 cells express CXCL12 and HCMV infection induces perinuclear sequestration of CXCL12 in SGHPL-4 cells. SGHPL-4
cells demonstrated positive staining for CXCL12 and mock-infected cells displayed diffuse staining for CXCL12 (A). SGHPL-4 cells were seeded on
chamber slides and serum starved for 24 hours. They were infected with either laboratory (Towne and Toledo) or clinical (TRpM1a) isolates of
HCMV for 24 hours, and then fixed and stained for CXCL12. In contrast, Towne (B), Toledo (C), and TRpMIA (D) were able to induce perinuclear
sequestration of CXCL12. UV-inactivated Towne-GFP (E) was unable to induce chemokine sequestration. No significant background staining was
seen in cells stained with secondary antibody and DAPI alone (F).
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jugated to phycoerythritin (PE). As shown in Figure 3A-B,
infection with HCMV significantly increased the percent-
age of cells expressing CXCR4 and CXCR7 on the cell sur-
face at all timepoints analyzed. The mean fluorescence
intensity (MFI) for CXCR4, corresponding to the number
of molecules of each receptor on the cell surface, was
increased at all timepoints analyzed, whereas the MFI for
CXCR7 was increased only at 72 and 96 hours post-
infection (data not shown).Figure 2 HCMV infection decreases secretion of CXCL12 by SGHPL-4
collected from mock-infected or HCMV-infected cells and CXCL12 secretion
cells secreted significantly less CXCL12 into their culture medium as compa
and HCMV-infected cells and quantitative real-time PCR was performed usi
in mRNA expression between mock-infected and HCMV-infected cells at anCXCR4 and CXCR7 mRNA expression is increased by
HCMV infection
Infection with HCMV induced upregulation of CXCR4
mRNA expression (p<0.001) at 8, 24, 48, and 96 hours
post-infection (Figure 3C). Peak upregulation of CXCR4
mRNA expression was seen at 96 hours, with a 16-fold
increase in expression between HCMV-infected and
mock-infected samples. Although a statistically signifi-
cant (p<0.001) upregulation of CXCR7 mRNA expression
was seen at 48 hours post-infection, barely a two-foldcells but mRNA expression is unaffected. Supernatants were
was analyzed by ELISA (A). At all timepoints studied, HCMV-infected
red to mock-infected controls. RNA was isolated from mock-infected
ng primers specific for CXCL12 (B). There was no significant difference
y timepoint analyzed. (*, p<0.05; **, p<0.01; ***, p<0.001).
Table 1 Real-time PCR primer sequences
Gene Sequence Accession
number
CXCL12 Sense: 50-ACT-GGG-TTT-GTG-ATT-GCC-TCT-GAA-30 NM00117813
Antisense: 50-GGA-ACC-TGA-ACC-CCT-GCT-GTG-30
CXCR4 Sense: 50-TTG-TGG-GTG-GTT-TGT-GTT-CCA-30 NM003467
Antisense: 50-CTG-TGG-TCT-TGA-GGG-CCT-TG-30
CXCR7 Sense: 50-GGC-TAT-GAC-ACG-CAC-TGC-TAC-A-30 NM020311
Antisense: 50-TGG-TTG-TGC-TGC-ACG-AGA-CT-30
36B4 Sense: 50-TGG-AGA-CGG-ATT-ACA-CCT-TC-30 NM001002
Antisense: 50-CTT-CCT-TGG-CTT-CAA-CTT-TAG-30
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inactivated HCMV did not alter the mRNA expression of
CXCR4 or CXCR7 at any timepoint analyzed, indicating
that viral gene expression is required for these findings
(data not shown).
Absolute protein levels of CXCR4 and CXCR7 are
unchanged by HCMV infection
Given the upregulation of surface and mRNA expression
of CXCR4 and CXCR7 following HCMV infection, it
seemed likely that total protein levels may likewise be
increased. Serum-starved SGHPL-4 cells were mock-
infected or infected with wild-type HCMV for 24, 48, 72,
or 96 hours. Protein lysates were harvested at appropri-
ate time points post-infection and equal amounts of total
protein were subjected to Western blotting for CXCR4
and CXCR7. A single band corresponding to CXCR4
was detected in all samples. Surprisingly, the band inten-
sity for both receptors was not altered at any time point
post-infection (Figure 3E).
HCMV infection blocks CXCL12-induced migration and
invasion
To determine whether HCMV infection affects CXCL12-
induced EVT migration and invasion, the functional re-
sponse of HCMV-infected cells to exogenous CXCL12 was
assessed using a quantitative FluoroBlok assay that has been
used widely to characterize cytotrophoblast migration and
invasion to chemotactic stimuli [13,32,33]. Recombinant
human epidermal growth factor (EGF) (10 ng/ml) was used
routinely as a positive control for each assay, as SGHPL-4
cells significantly migrate and invade in response to EGF,
while infection with HCMV abrogates this response (data
not shown) [13].
CXCL12 induced migration of SGHPL-4 cells to a greater
extent than that observed using serum-free culture medium
alone (negative control) (Figure 4A). HCMV infection
blocked migration toward recombinant human CXCL12 at
both 50 ng/ml and 10 ng/ml (p<0.001) to the level seen in
negative control wells containing serum-free culturemedium alone (Figure 4A). The specific role of CXCR4 in
this result was investigated using a neutralizing antibody
directed against the receptor (clone 12G5) or an isotype-
matched mouse anti-human IgG control. Data not shown)
interestingly, the impaired migration seen following HCMV
infection was more dramatic than that seen following
neutralization of CXCR4. In fact, 12G5 was unable to sig-
nificantly inhibit migration toward CXCL12 at a concentra-
tion of 50 ng/ml, although it was able to inhibit migration
toward 10 ng/ml of the recombinant chemokine (p<0.001).
Control IgG did not have a statistically significant impact
on migration (data not shown).
CXCL12 also induced invasion of SGHPL-4 cells versus
cells incubated with serum-free medium alone (Figure 4B).
SGHPL-4 cell invasion through Matrigel toward CXCL12
at both 50 ng/ml and 10 ng/ml was also significantly
impaired following HCMV infection (p<0.001), again recap-
itulating the weak background migration toward serum-
free culture medium. In contrast to the migration assays,
pre-treatment with 12G5 was able to significantly inhibit
invasion toward both 50 ng/ml and 10 ng/ml of CXCL12
(p<0.001), however, not to the level seen in HCMV-infected
cells. Once again, control IgG did not have a significant ef-
fect on invasion (data not shown).
Discussion
The early events in placentation, including proliferation
of villous cytotrophoblasts, as well as their adoption of
an invasive phenotype, are inhibited by infection with
HCMV [13,34-38]. This ubiquitous human pathogen,
which generally causes subclinical disease in immuno-
competent patients, can have devastating consequences
for both the mother and developing fetus when primary
infection occurs in the first trimester of pregnancy [1-3].
Previous studies have shown that HCMV impairs the re-
sponse of EVT to soluble EGF in terms of their ability to
proliferate, migrate and invade [13]. However, the effect
of HCMV on the response of EVT to other soluble med-
iators has largely been unexplored. The aim of this study
was to specifically address the effect of HCMV infection
on the cellular localization and expression of the
CXCL12 chemokine and its receptors, CXCR4 and
CXCR7, in the extravillous cytotrophoblast cell line
SGHPL-4 and to determine whether HCMV affects EVT
migration and invasion.
Immunofluorescence staining for CXCL12 in HCMV-
infected SGHPL-4 cells demonstrated clear and distinct
perinuclear accumulation of the chemokine. CXCL12
sequestration was dependent on viral gene expression,
as perinuclear accumulation of the chemokine was not
seen after infection with UV-inactivated virus. Add-
itionally, secretion of CXCL12 into culture medium
was inhibited by infection with HCMV, whereas
mRNA expression of CXCL12 was unaffected by viral
Figure 3 HCMV infection alters expression of CXCR4 and CXCR7. SGHPL-4 cells were mock-infected or infected with HCMV, and then CXCR4
and CXCR7 receptor expression was determined. HCMV infection induced upregulation of cell surface staining for CXCR4 (A) and CXCR7 (B) at all
time points studied. (*, p<0.05; **, p<0.01; ***, p<0.001). Total RNA was harvested from mock-infected or HCMV-infected SGHPL-4 cells, and
analyzed by real-time PCR using primers specific for CXCR4 and CXCR7. HCMV infection induced a significant upregulation of CXCR4 mRNA
expression (C) at 8, 24, and 48 hours post-infection. A modest but significant upregulation of CXCR7 mRNA expression was seen at 48 hours post-
infection (D). Protein lysates from mock-infected and HCMV-infected cells were analyzed by Western blot for CXCR4 and CXCR7 expression. No
differences in absolute protein levels were seen at any time point analyzed (E).
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decrease in CXCL12 secretion seen following HCMV
infection is a function of decreased release or deg-
radation of preformed chemokine, rather than altered
generation of new transcripts or protein. Colocaliza-
tion studies are needed to determine the precise sub-
cellular localization of CXCL12 in HCMV-infected
cells to more clearly delineate whether there is an in-
hibition of secretion or an increase in degradation of
the chemokine.The effect of HCMV infection on expression of the
CXCL12 receptors, CXCR4 and CXCR7, was also inves-
tigated. Infection of SGHPL-4 cells with HCMV induced
upregulation of both receptors to the cell membrane.
HCMV infection also upregulated mRNA expression of
both CXCR4 and CXCR7; however, protein expression
levels of both chemokine receptors were unaffected by
HCMV infection. This finding may be due to increased
protein degradation through proteasome and/or autop-
hagosome activation, viral hijacking of the cellular
Figure 4 HCMV infection blocks the ability of SGHPL-4 cells to migrate or invade toward CXCL12. Serum-starved SGHPL-4 cells were
mock-infected or infected with Towne HCMV (MOI of 1) for 24 hours. Mock-infected cells were also pretreated with a neutralizing antibody
against CXCR4 (12G5) prior to the assay. The cells were loaded into Fluoroblok inserts with 8 μm pores and chemoattractants (CXCL12 or EGF)
were loaded into the lower chamber. Migration was allowed to proceed for 6 hours, whereas invasion assays were incubated for 24 hours, at
which point they were labeled with Calcein AM and 10X images were acquired. HCMV infection significantly impaired migration (A) and invasion
(B) toward CXCL12 at both 50 ng/ml and 10 ng/ml (p<0.0001). Although antibody-mediated (12G5) neutralization of CXCR4 significantly
decreased migration (p<0.0001) and invasion (p<0.0001) toward CXCL12, its effect was not as pronounced as that seen following infection with
HCMV. (***, p<0.001).
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mRNA, CXCL12 endocytic trafficking to lysosomes for
degradation and/or other possible posttranscriptional
regulatory mechanisms. Upregulation of cell surface
CXCR7 expression in parallel to that seen for CXCR4
was not surprising, since these receptors were recently
shown to heterodimerize [28]. However, the precise
function of CXCR7 in SGHPL-4 cells (and in cytotro-
phoblasts in general) remains to be elucidated. If CXCR7
in fact acts as a chemokine sink, upregulation of this re-
ceptor to the cell surface may mediate sequestration of
CXCL12 following HCMV infection [26,27,29,39].
Despite recruitment of CXCR4 and CXCR7 to the cell
membrane, both migration and invasion toward
CXCL12 were almost completely inhibited following
HCMV infection. These results indicated that despite
increased cell surface receptor expression, HCMV-
infected cells were unable to respond to a chemotactic
gradient of CXCL12. Blockade of CXCR4 function with
a neutralizing antibody (12G5) partially inhibited migra-
tion and invasion toward CXCL12, but to a lesser extent
than the inhibition seen following HCMV infection, sug-
gesting that both CXCR4 and CXCR7 may mediate mi-
gration and invasion in response to CXCL12. In general,
upregulation of cell surface expression of CXCR4 is
associated with a pro-migratory phenotype. Treatment
of adult neuronal stem cells or human mesenchymalstem cells with cytokines including IL-3, IL-6, and IL-10
induces cell surface expression of CXCR4, which corre-
lates with increased cellular migration [40,41]. Addition-
ally, the macrolide antibiotic erythromycin, which
demonstrates potent anti-inflammatory effects, has been
shown to upregulate cell surface expression of CXCR4
on microvascular endothelial cells, promoting their mi-
gration into sites of tissue injury [42]. Therefore, the
finding that CXCL12-induced migration and invasion
were decreased in spite of upregulated cell surface ex-
pression of CXCR4 and CXCR7 in HCMV-infected
SGHPL-4 cells is somewhat surprising. Given the
decreased secretion of CXCL12 following HCMV infec-
tion of SGHPL-4 cells, it is possible that HCMV-infected
cells upregulate cell surface and mRNA expression of
CXCR4 and CXCR7 as an attempt to compensate for
lack of or dysregulated autocrine signaling.
Ultimately, these studies demonstrate that HCMV
inhibits CXCL12-induced EVT migration and invasion
that correlates with sequestration and reduced secretion
of the chemokine CXCL12. The molecular mechanism
(s) by which HCMV inhibits cytotrophoblast migration
and invasion during placentation is not known but likely
involves, in general, the virus hijacking the cellular ma-
chinery and thus affecting cellular morphology, cytoskel-
etal arrangement, endosomal trafficking and invadosome
formation.
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Collectively, these studies demonstrate that CXCL12 is
sequestered during HCMV infection in placental cells and
that HCMV inhibits EVT migration and invasion. Whether
the ability of HCMV to inhibit EVT invasive properties is
due to dysregulation of the CXCL12/CXCR4 signaling axis
remains undetermined. HCMV dysregulation of placental
function associated with pregnancies complicated by pri-
mary HCMV infection is mediated in part through a mech-
anism that involves inhibition of EVT migration and
invasion induced by CXCL12. Since HCMV similarly inhi-
bits EVT migration and invasion induced by other factors
present at the fetal-maternal interface, HCMV may likely
be affecting cellular function to abrogate EVT invasiveness.
Future studies may elucidate convergent pathways that




The human extravillous trophoblast cell line SGHPL-4
(kindly provided by Drs. Guy Whitley and Judith
Cartwright, St. George’s University, London, England)
was used for these studies. This cell line was derived
from first-trimester chorionic villous tissue immortalized
with SV40 large T antigen. These cells have been shown
to share many characteristics with first-trimester primary
EVT, including expression of cytokeratin-7, HLA-G,
hCG, and hPL when cultured on an artificial extracellu-
lar matrix (Matrigel) [43]. These cells are permissive for
the full replication cycle of human cytomegalovirus
[13,44]. SGHPL-4 cells were cultured in Ham’s F10
medium, supplemented with 10% fetal bovine serum,
2 mM L-glutamine, 100 U/ml penicillin G, and 100 mg/ml
streptomycin (all from Invitrogen, Carlsbad, CA) at 37°C in
5% CO2. For serum starvation, the media was replaced
with Ham’s F10 prepared as above but with reduced
FBS (0.5%).
HCMV was propagated in human foreskin fibroblast
cells (HFF; ATCC, Manassas, VA). These cells were
maintained in DMEM supplemented with 10% FBS, 2
mM L-glutamine, 100 U/ml penicillin G, and 100 mg/ml
streptomycin (all from Invitrogen) at 37°C in 5% CO2.
Viral strains and propagation
Several viral strains were used for these studies. Towne-
GFP (an attenuated but well-characterized laboratory
isolate) and TRpM1a (a clinical isolate) were kindly pro-
vided by Dr. Dan Streblow (Oregon Health Sciences
University, Beaverton, OR). Other viral strains (Toledo
and Towne) were purchased from ATCC. Total virus
was prepared from cell culture supernatants of infected
HFFs as previously described [13]. Briefly, infected HFFs
were incubated at 37°C in 5% CO2 in DMEM containing10% FBS until 100% of the cells demonstrated cytopathic
effect (CPE). Regular feeding of the cells was then ceased
and the cells were incubated for an additional 4–5 days,
at which point the cells were easily detached from the
plastic. Supernatants were collected and clarified by cen-
trifugation for 10 minutes at 2500 rpm at 4°C. The virus
was aliquoted and frozen at −80°C and then stored in li-
quid nitrogen. Viral titers were calculated by staining for
the immediate early antigens of HCMV 24 hours post-
infection.HCMV infections
All HCMV infections were carried out as follows. Briefly,
SGHPL-4 cells were seeded on tissue culture plates and
allowed to adhere for at least 24 hours at 37°C. The cells
were then washed with 1X Dulbecco’s phosphate buf-
fered saline (DPBS, Invitrogen) and serum-starved in
Ham’s F10 medium containing 0.5% FBS for an add-
itional 24 hours. HCMV was diluted in serum-free
Ham’s F10 in a minimal volume for the surface area to
be infected. The cells were incubated with virus at 37°C
for 90 minutes with occasional rocking. Unbound virus
was removed by aspiration and fresh Ham’s F10 contain-
ing 0.5% FBS was added to the infected cells. For each
experiment, control cells were mock-infected using
equivalent volumes of media.
HCMV was UV-inactivated as previously described
[13]. Briefly, virus thawed on ice was spread onto a 10-cm
plate and cross-linked four times at 426 mJ, with gentle
mixing after each cycle. The virus was then diluted and
used for infections as described above.Antibodies and reagents
For immunofluorescence, the following primary anti-
bodies were used: mouse anti-human CXCL12 (R&D
Systems, Minneapolis, MN, MAB350). Detection of
HCMV immediate early (IE) gene expression was per-
formed using mouse anti-human cytomegalovirus IE 1/2
(Millipore, Billerica, MA, MAB810). Isotype-matched
secondary antibodies conjugated to either Alexa-488,
Alexa-555, or Alexa-594 (Invitrogen) were used as indi-
cated. For flow cytometric analysis of chemokine recep-
tor expression, mouse anti-human CXCR4 (eBioscience,
San Diego, CA, 12–9999) and mouse anti-human
CXCR7 (Biolegend, San Diego, CA, 331104) antibodies
directly conjugated to phycoerythritin (PE) were used.
For Western blotting, the following antibodies were
used: rabbit anti-human CXCR4 (Abcam, ab2074),
rabbit anti-human CXCR7 (Abcam, ab72100), and rab-
bit anti-human beta actin (Abcam, ab8227). Appropri-
ate secondary antibodies conjugated to horseradish
peroxidase (HRP) were used for detection (1:5000,
KPL, Gaithersburg, MD).
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tems and reconstituted in DPBS supplemented with 0.1%
bovine serum albumin. Neutralization of CXCR4 activity
was obtained with mouse anti-human CXCR4 antibody
(clone 12G5, Abcam ab21555) diluted to a final concentra-
tion of 10 μg/ml in serum-free Ham’s F10 medium.
ELISA analysis
SGHPL-4 cells were infected with HCMV at an MOI of
1 and supernatants were harvested at appropriate time-
points post-infection. The supernatants were spun at
2500 rpm to pellet any cellular debris, aliquoted, and
frozen at −80°C prior to analysis.
Secretion of CXCL12 into cell culture supernatants
was analyzed by enzyme-linked immunosorbent assay
(ELISA, R&D Systems, SDF-1α Quantikine Immuno-
assay kit) per the manufacturer’s instructions. ELISA
plate absorbance was read at 450 nm with correction at
540 nm using a μQuant Universal Microplate Spectro-
photometer (BioTek Instruments; Winooski, VT). The
data were normalized to a standard curve prepared with
serial dilutions of recombinant CXCL12.
Immunofluorescence
SGHPL-4 cells were plated on 4-well chamber slides
coated with collagen type IV (BD Biosciences), and then
mock-infected or infected with HCMV as outlined above.
At appropriate timepoints, the cells were fixed with 2%
methanol free paraformaldehyde (Ted Pella, Inc. Redding,
CA) for 20 minutes at room temperature. Free aldehydes
were quenched by incubation with 50mM NH4Cl for 10
minutes, and the cells were permeabilized with 0.1%
Triton-X 100 in DPBS for 8 minutes. The slides were
blocked with DPBS supplemented with 5% BSA and
0.05% Triton-X 100 for 1 hour at room temperature. Pri-
mary antibodies were diluted in DPBS supplemented with
1% BSA and 0.05% Triton-X 100 for 1 hour. After exten-
sive washing, secondary antibodies conjugated to Alexa-
488, Alexa-555, or Alexa-594 (Invitrogen) were added and
nuclei were counterstained with 40,6-diamidino-2-pheny-
lindole,dihydrocholoride (DAPI, Invitrogen). The slides
were then washed with DPBS and mounted with Prolong
Antifade mounting medium (Invitrogen) and covered with
glass coverslips. For each experiment, wells stained with
secondary antibodies alone were included as controls for
background fluorescence. Slides were imaged using a Zeiss
Axio Plan II microscope (Thornwood, NY) and images
were deconvolved using SlideBook 5.0 Intelligent Imaging
Software (Intelligent Imaging Innovations; Denver, CO).
Flow cytometry
Cell surface expression of CXCR4 and CXCR7 was ana-
lyzed by flow cytometry. SGHPL-4 cells grown in 6-well
plates were serum-starved for 24 hours at 37°C. Thecells were then infected with Towne HCMV at an MOI
of 1 and incubated for an additional 24, 48, 72, or 96
hours. The samples were blocked in DPBS containing
2% FBS for 20 minutes on ice prior to incubation in
blocking solution containing antibodies to CXCR4 and
CXCR7 directly conjugated to PE for 30 minutes on ice
in the dark. After washing, the samples were fixed in 4%
methanol-free formaldehyde (Ted Pella, Inc.) for 20
minutes in the dark, and then washed with DPBS. The
samples were stored in DPBS containing 0.1% BSA and
0.1% NaN3 at 4°C until they were run on the flow cyt-
ometer. The samples were analyzed using a BD FACSCa-
libur on CellQuest Pro software (BD Biosciences, San
Jose, CA). Unstained control cells and cells stained with
PE-conjugated isotype controls were used to set the ac-
quisition controls and voltages. The data were analyzed
using CellQuest Pro software (BD Biosciences).
Western blotting
SGHPL-4 cells were plated on 10-cm plates and grown to
near confluency, then serum-starved in Ham’s F10 con-
taining 0.5% FBS for 24 hours. For long-term HCMV in-
fection studies, the cells were infected with HCMV at
MOI of 1 for 90 minutes at 37°C, at which point unbound
virus was removed and the cells were incubated in Ham’s
F10 containing 0.5% FBS for 24–96 hours. Mock-infected
controls were included for each time point.
Protein lysates were harvested as previously described
[13,45]. The plates were washed in cold DPBS and the
cells were lysed with RIPA buffer containing a proteinase
inhibitor cocktail (PIC), two phosphatase inhibitors (PhIC
I and II) and 1mM phenylmethanesulfonylfluoride (PMSF;
all from Sigma-Aldrich; St. Louis, MI). The lysates were
sheared and. cellular debris was removed. Total protein
concentrations were estimated with the Micro BCA pro-
tein assay kit (Thermo Fisher; Rockford, IL).
Total protein (25 μg per sample) were separated on 4-
12% NuPage SDS-polyacrylamide gels (Invitrogen). Pro-
teins were transferred by blotting to PVDF membranes
(Invitrogen) and were blocked in 5% non-fat dry milk
(NFDM) in Tris-buffered saline containing 0.1% Tween-
20 (TBST) prior to incubation with primary antibody
overnight at 4°C. After extensive washing, the blots were
incubated with secondary antibodies (goat anti-mouse
IgG, rabbit anti-goat IgG or goat anti-rabbit IgG, 1:5000,
KPL Protein Research Products) for 1 hour at room
temperature. Antigen-antibody complexes were detected
using an enhanced chemiluminescence system (Thermo
Fisher) and digital images of blots were acquired using
an LAS4000 imager (Kodak, Rochester, NY). Blots were
subsequently stripped in Restore Plus Western Blot
Stripping Buffer (Thermo Fisher) and reprobed using a
rabbit polyclonal antibody directed against human β-
actin (Abcam) as a loading control.
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Total RNA was isolated from serum-starved SGHPL-4
cells that had been mock-infected, infected with UV-
inactivated HCMV, or infected with the Towne HCMV
strain. RNA was isolated using the Qiagen RNeasy Mini
kit according to the manufacturer’s instructions (Qiagen,
Valencia, CA). Isolated RNA was treated with DNase I
(Ambion, Inc.; Austin, TX) and concentration was mea-
sured using a NanoDrop Spectrophotometer (Thermo
Scientific). Total RNA (1 μg) was reverse transcribed
with iScript cDNA Synthesis Kit (Biorad; Hercules, CA)
as per the manufacturer’s instructions.
Quantitative real-time PCR was performed using the
iCycler Real-Time PCR Detection System (BioRad). Spe-
cific primer pairs used in these aims are listed in Table 1.
PCR cycling conditions were as follows: 1 denaturing
step at 95°C for 3 minutes, 40 cycles of 95°C for 15 sec-
onds followed by 60°C for 30 seconds, 1 cycle at 95°C
for 1 minute, and 1 cycle of 60°C for 1 minute. Follow-
ing the PCR reaction, melt curve reactions were per-
formed to confirm the specificity of each primer pair
and exclude the presence of primer dimers from the re-
action. The melt curve was performed via 80 cycles be-
ginning at 55°C and incrementally increasing by 0.5°C
every 30 seconds. Relative quantitation was determined
using the comparative CT method with data normalized
to 36B4 and calibrated to the average CT of mock-
infected control at the specified time point.
Migration and invasion assays
Cellular migration and invasion were determined using
the quantitative FluoroBlok assay as previously described
[13]. Serum-starved SGHPL-4 cells were mock- infected
or infected with Towne HCMV as described above. 24
hours post-infection, the cells were trypsinized and loaded
into FluoroBlok inserts with 8 μm pores (BD Biosciences).
To assess the role of CXCR4 on migration and invasion
toward CXCL12, some samples were pre-treated with
12G5 (a neutralizing antibody against CXCR4) or a mouse
IgG isotype control, both at 10 μg/ml, for 30 minutes prior
to the beginning of the migration or invasion assay.
For invasion assays, the inserts were pre-coated with
growth factor reduced Matrigel (BD Biosciences) diluted
1:10 in serum-free Ham’s F10 and the Matrigel was allowed
to solidify for 1 hour at 37°C. For migration assays, the
inserts were left uncoated. Each well was loaded with
2.5x105 cells in a total volume of 200 μl of serum-free
medium. The lower wells of the chamber were loaded with
serum-free culture medium containing varied doses of re-
combinant CXCL12. Human EGF (10 ng/ml) was used as
a positive control for all assays and serum-free medium
alone was used as a negative control. Invasion assays were
allowed to proceed for 24 hours whereas migration assays
were incubated for 6 hours.At the end of the experimental time period, the plates
were removed from the incubator and any cells remaining
on top of the insert were removed by aspiration. The cells
on the lower surface of the inserts were then fluorescently
labeled with Calcein AM (Invitrogen). The plates were
then incubated at 37°C for an additional hour, which
allowed for fluorescent labeling of the invasive cells on the
lower surface of the membrane. Four 10X pictures of each
well were taken using a Nikon TE300 inverted epifluores-
cent microscope (Olympus Optical Company, Lewisville,
TX) and the mean fluorescence per image was determined
using ImageJ software (NIH, Bethesda, MD).
Statistical analysis
The data are presented as mean ± standard error of the
mean [46]. Data were compared to negative control
samples and each other by one-way analysis of variance
(ANOVA) followed by Dunnett’s multiple comparisons
post hoc test (GraphPad Prism, Version 5, La Jolla, CA).
For experiments with only two groups, data were ana-
lyzed by one-tailed unpaired t test. Statistical significance
is denoted on figures with asterisks (*; p<0.05, **; p<0.01,
***; p<0.001).
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